Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Gastric and Esophagogastric Junction Adenocarcinoma × Ipilimumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 1 Recurrent Squamous Cell Lung Carcinoma 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Gastric and Esophagogastric Junction Adenocarcinoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Advanced Solid Tumors 1

Interventions

Nivolumab 1 Ipilimumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03443856 2024-01-05

VESTIGE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting

Gastrointestinal

Gastric and Esophagogastric Junction Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡